Malignant glioma: Should chemotherapy be overthrown by experimental treatments?
Open Access
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (6) , 589-600
- https://doi.org/10.1023/a:1008267312782
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II studyEuropean Journal Of Cancer, 1996
- The charing cross hospital experience with temozolomide in patients with gliomasEuropean Journal Of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapyEuropean Journal Of Cancer, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumorsJournal of Neuro-Oncology, 1993
- Salvage chemotherapy for recurrent primary brain tumors in childrenThe Journal of Pediatrics, 1988